Sangre de grado Croton lechleri Müll.Arg.
Also called: sangre de drago, dragon's blood (Croton), Croton draco var. cordatus (synonym)
Sangre de grado is the red latex of Croton lechleri, a tree of western South America used in Amazonian traditional medicine. Crofelemer, a proanthocyanidin drug purified from this latex, is a US prescription medicine; crude sap products are different preparations.
- Category
- Botanical
- Part used
- Red latex (sap)
- Strongest evidence
- B Some positive trials
- Native range
- Native to western South America (POWO: "W. South America")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. This entry cites 3 RCTs of sangre de grado products alone, all of latex-derived proanthocyanidin preparations, not crude sap: SP-303 for travelers' diarrhea, and crofelemer, a prescription drug, for HIV-related diarrhea and for diarrhea-predominant IBS. [3]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CSkin and hair1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Acute travelers' diarrhea (latex-derived SP-303) | B | In an RCT of 184 travelers, SP-303 125-500 mg four times daily for 2 days shortened time to the last unformed stool (30.3-32.6 h vs 38.7 h with placebo). [3] |
| Non-infectious diarrhea in adults with HIV (crofelemer, prescription drug) | B | In the phase 3 ADVENT trial (376 patients), more patients responded to crofelemer 125 mg twice daily than to placebo over 4 weeks (17.6% vs 8.0%). [4] |
| Insect bites and minor skin reactions (topical balm) | C | Pest-control workers preferred a sangre de grado balm over placebo for itching, pain and swelling from insect bites, cuts and plant reactions; the published abstract gives few trial details. [5] |
Main constituents: Proanthocyanidins, the predominant group; alkaloids, diterpenoids, phytosteroids, saponins and other phenolics are also reported [1]; SP-303: a large proanthocyanidin oligomer isolated from the latex (the material tested in the travelers' diarrhea trial) [6]; Crofelemer: an oligomeric proanthocyanidin mixture of catechin, epicatechin, gallocatechin and epigallocatechin units (average degree of polymerization 5 to 7.5) [7]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- SP-303 125 mg, 250 mg or 500 mg four times a day for 2 days (travelers' diarrhea trial). [3]
- Crofelemer 125 mg twice daily (ADVENT trial stage II). [4]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox (Dragon's Blood, updated June 3, 2024): likelihood score E, unlikely cause of clinically apparent liver injury …
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines1 listed
Zidovudine, nelfinavir, lamivudine (crofelemer data)
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- NIH LiverTox scores dragon's blood E (unlikely cause of clinically apparent liver injury); in crofelemer trials, mild, transient, asymptomatic aminotransferase elevations occurred in 1% to 2% of subjects. [8]
- SP-303 was well tolerated at all doses tested in the travelers' diarrhea trial. [3]
- Crofelemer was minimally absorbed, and its safety profile was comparable to placebo in the ADVENT trial. [4]
- Crofelemer label: infectious causes of diarrhea should be ruled out before starting it; it is not indicated for infectious diarrhea. [7]
Identity, quality and standardization
- "Dragon's blood" also names red resins from Calamus draco, Dracaena species and Pterocarpus species, so the common name alone does not identify Croton lechleri. [8]
- Sap chemistry differs between geographic areas and alkaloid chemotypes have been described; the reviewer noted that materials for clinical use need standardization. [2]
Regulatory status
- US: FDA states that, by law, it does not approve dietary supplements or their labeling before they are marketed; firms are responsible for the safety and labeling of their products. [10]
- US: No NDI notification naming sangre de grado (Croton lechleri) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [11]
- US drug: crofelemer (Mytesi), a botanical drug substance derived from the red latex of Croton lechleri, is a prescription anti-diarrheal indicated for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming sangre de grado (Croton lechleri) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]
- Crofelemer (Mytesi), derived from Croton lechleri red latex, is marketed in the US as a prescription drug, not a dietary supplement. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox (Dragon's Blood, updated June 3, 2024): likelihood score E, unlikely cause of clinically apparent liver injury; no published reports of clinically apparent liver injury from dragon's blood or crofelemer. [P6]
Interactions with medicines
- Zidovudine, nelfinavir, lamivudine (crofelemer data): Crofelemer 500 mg four times daily for 5 days did not change zidovudine or nelfinavir exposure; lamivudine exposure fell 20%, which was not considered clinically important. [P2]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- LiverTox notes that "dragon's blood" is a red resin from several plants (Calamus draco, Croton lechleri, Pterocarpus species, Dracaena cinnabari and D. draco), so the trade name does not by itself identify the species. [P6]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of the dietary ingredient (at least one appropriate test or examination before use) — 21 CFR 111.75(a)(1)(i) requires identity verification of every component that is a dietary ingredient, unless FDA exempts the firm on petition under 111.75(a)(1)(ii). [P8]
- Confirmation of botanical source (Croton lechleri latex versus other 'dragon's blood' resins) — Resins from several unrelated plants share the name dragon's blood (LiverTox). [P6]
- Chemical standardization of the sap — Sap chemistry varies by geographic area and alkaloid chemotypes exist (Jones 2003). [P7]
Supply and conservation
- The Mytesi label states that its Croton lechleri raw material is harvested from the wild in South America. [P2]
Absorption in people
- Crofelemer is minimally absorbed after oral dosing; plasma concentrations in healthy adults and HIV-positive patients were below the 50 ng/mL quantitation limit. [P2]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- de Albuquerque RDDG, et al. A review on phytochemistry and recent pharmacology of Dragon's Blood (Croton lechleri), a multifunctional ethnomedicinal resource from the Amazon forest. Planta Med 2025;91(8):409-418 (PMID 40043740), 2025-07. pubmed.ncbi.nlm.nih.gov
- DailyMed. MYTESI (crofelemer) delayed-release tablets, prescribing information (label revised 11/2020; SPL published Aug 14, 2026), 2026-08-14. dailymed.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Agents classified by the IARC Monographs (list of classifications, checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox. Dragon's Blood (last update June 3, 2024), 2024-06-03. ncbi.nlm.nih.gov
- Jones K. Review of sangre de drago (Croton lechleri) - a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J Altern Complement Med 2003;9(6):877-96 (PMID 14736360), 2003-12. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75 (current as of October 27, 2026), 2026-10-27. ecfr.gov
Sources
- de Albuquerque RDDG, et al. A review on phytochemistry and recent pharmacology of Dragon's Blood (Croton lechleri), a multifunctional ethnomedicinal resource from the Amazon forest. Planta Med 2025;91(8):409-418 (PMID 40043740), 2025-07. pubmed.ncbi.nlm.nih.gov
- Jones K. Review of sangre de drago (Croton lechleri) - a South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J Altern Complement Med 2003;9(6):877-96 (PMID 14736360), 2003-12. pubmed.ncbi.nlm.nih.gov
- DiCesare D, et al. A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico. Am J Gastroenterol 2002;97(10):2585-8 (PMID 12385443), 2002-10. pubmed.ncbi.nlm.nih.gov
- Macarthur RD, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial). HIV Clin Trials 2013;14(6):261-73 (PMID 24334179), 2013-11. pubmed.ncbi.nlm.nih.gov
- Miller MJ, et al. Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. J Invest Dermatol 2001;117(3):725-30 (PMID 11564183), 2001-09. pubmed.ncbi.nlm.nih.gov
- Ubillas R, et al. SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). Phytomedicine 1994;1(2):77-106 (PMID 23195881), 1994-09. pubmed.ncbi.nlm.nih.gov
- DailyMed. MYTESI (crofelemer) delayed-release tablets, prescribing information (label revised 11/2020; SPL published Aug 14, 2026), 2026-08-14. dailymed.nlm.nih.gov
- NIH LiverTox. Dragon's Blood (last update June 3, 2024), 2024-06-03. ncbi.nlm.nih.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Croton lechleri Müll.Arg. (accessed 2026-10-29; Kew cannot warrant the accuracy of the data), 2026-10-29. powo.science.kew.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- Nee J, et al. Randomized clinical trial: crofelemer treatment in women with diarrhea-predominant irritable bowel syndrome. Clin Transl Gastroenterol 2019;10(12):e00110 (PMID 31800542), 2019-12. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.